AI drug discovery company Isomorphic Labs, a Google DeepMind spin-out, raised $2.1 billion last week, which saw participation from the UK’s Sovereign AI Fund Alphabet's majority ownership raises questions about where the London-based company fits wit...
Isomorphic Labs is British AI darling, but the cap table tells a different story